This study was primarily designed to investigate the role of FIASMA in management of tauopathy by inhibition of colonic ASM and focused on the relationship between colonic ASM activity, colonic ceramide levels, GM diversity, dysbiosis, intestinal wall permeability, systemic inflammation and tau pathology. Here, MAPT is linked to tauopathy.